Central Venous Catheter Insertion Site and Catheter Colonization and Bloodstream Infection in Pediatric Cardiac Surgery
| Registry | NCT03282292, acronym PRECiSE |
|---|---|
| Status | Withdrawn - Co-PI responsible for study procedures moved to another hospital |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, prevention |
| Sponsor | IRCCS Policlinico S. Donato (Other) |
| Conditions | Central Line-associated Bloodstream Infection (CLABSI), Central Venous Catheter Associated Bloodstream Infection, Heart; Surgery, Heart, Functional Disturbance as Result, Congenital Heart Disease, Newborn; Infection |
| Interventions | Internal jugular vein CVC insertion (Procedure) |
| Dates | start 2017-09-12, primary completion 2019-09-12, completion 2019-10-12, first posted 2017-09-13, last updated 2023-11-18 |
| Locations | 1 site in Italy |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Central Line-associated Bloodstream Infection (CLABSI) All trials for Central Venous Catheter Associated Bloodstream Infection All trials of Internal jugular vein CVC insertion
Randomized controlled trial comparing femoral vs internal jugular insertion site of central venous catheters (CVC) in newborns and infants undergoing cardiac surgery. The experimental hypothesis is that the jugular insertion site is superior to the femoral in terms of catheter colonization.
Background: in adult patients, the femoral site of insertion of CVC is notoriously at higher risk of colonization and central-line associated bloodstream infection (CLABSI) than other sites (jugular or subclavian). In pediatric patients, the femoral site is more commonly used than in adult patients, but there is no sound data on catheter colonization and CLABSI related to the insertion site. The experimental hypothesis of this randomized controlled trial (RCT) is that the jugular insertion site is less likely to induce catheter colonization and CLABSI than the femoral site.
Methods: 160 patients under 1 year and scheduled for cardiac surgery will be included in this RCT; patients will be randomly allocated to the jugular (J Group) or Femoral (F Group). CVC insertion will be performed by one out of three selected expert operators.
The primary endpoint is the catheter colonization based on identification of bacterial grow into the catheter at removal time; CLABSI and CRBSI rate based on the same bacterial identification into the catheter tip and in the blood culture performed in case of signs and symptoms of infection.
Secondary endpoints are mechanical complications defined as arterial puncture immediately identified during procedure, hemothorax and pneumothorax; and procedural difficulty during insertion defined as number of attempts, no guidewire progress, duration of the procedure (time from the completion of the sterile precaution barriers and the catheter fixation.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Jugular | Experimental | Procedure: Internal jugular vein CVC insertion | CVC insertion in the left or right internal jugular vein |
| Femoral | Active comparator | Procedure: Internal jugular vein CVC insertion | CVC insertion in the right or left femoral vein |
Sex: All, ages: any to 1 Year
Inclusion Criteria: Planned cardiac surgery Age <1 year Eligibility for both insertion sites (jugular and femoral) for CVC Availability of at least one out of the three chosen expert operators Exclusion Criteria: Emergency surgery Known vascular anatomic anomalies Previous cardiac surgery in the last 6 months No expert operator availability Intensive Care unit before surgery Central venous catheter inside at the time of randomization Withdraw criteria (only for the first endpoint): Impossibility to placement catheter in the selected site.
| Facility | City | Country | Status |
|---|---|---|---|
| IRCCS Policlinico S.Donato | San Donato Milanese, Milan | Italy |